Obiettivo
Chronic pain is estimated to affect 15-20% of children with varying disabilities. Due to the paucity of clinical information and appropriate medicinal products, in clinical practice paediatric patients are often under-treated causing profound impact on their QoL.
To date, opioids, non-steroid anti-inflammatory drugs (NSAIDs), antidepressants and anticonvulsants are used to treat pain, but only few of these include a paediatric authorisation. In addition, the few available paediatric drugs have a very different authorisation profile across Europe and, when not approved in paediatrics, they are used off-label to cover the high therapeutic need, thus exposing children to unnecessary risks of dosing errors and increasing ADRs.
The GAPP Project is focused on the development of gabapentin for the treatment of paediatric chronic pain, a condition where gabapentin, as demonstrated in adults, is expected to bring great benefit to children.
To this end, a large international scientific Consortium is set up, with experienced professionals in the field of pain that will work together with a Pharmaceutical Company committed to apply for a PUMA using the project results.
Within GAPP, age-appropriate formulation will be developed and two randomised, comparator-controlled clinical trials and a bridging study will be conducted in compliance to a submitted Paediatric Investigation Plan (PIP, Summary Report Day 90 - EMEA-001310-PIP01-12) in order to investigate appropriate dosages, efficacy and safety of gabapentin in the paediatric population. Further to this, in order to ensure the safety of gabapentin in very young children, a non clinical study will be conducted to evaluate the neurotoxic potentil of the drug. At the end of the project, gabapentin can be proposed for treatment of chronic pain in children both as monotherapy and as adjuvant therapy.
Campo scientifico
Invito a presentare proposte
FP7-HEALTH-2013-INNOVATION-1
Vedi altri progetti per questo bando
Meccanismo di finanziamento
CP-FP - Small or medium-scale focused research projectCoordinatore
70122 Bari
Italia
Mostra sulla mappa
Partecipanti (16)
3015 GD Rotterdam
Mostra sulla mappa
35127 Padova
Mostra sulla mappa
35138 Padova
Mostra sulla mappa
70124 Bari
Mostra sulla mappa
26900 LODI
Mostra sulla mappa
Partecipazione conclusa
50406 Tartu
Mostra sulla mappa
20122 Milano
Mostra sulla mappa
Partecipazione conclusa
67100 L'Aquila
Mostra sulla mappa
WC1E 6BT London
Mostra sulla mappa
91054 Erlangen
Mostra sulla mappa
1001 Tirana
Mostra sulla mappa
75012 Paris
Mostra sulla mappa
Partecipazione conclusa
46015 VALENCIA
Mostra sulla mappa
1018 RG Amsterdam
Mostra sulla mappa
16147 Genova
Mostra sulla mappa
115 27 ATHINA
Mostra sulla mappa